Subscribe to RSS

DOI: 10.1055/s-0041-1736569
Update in Imaging Evaluation of Bone and Soft Tissue Sarcomas
Article in several languages: português | EnglishFinancial Support The authors declare that they have not received financial support from public, private, or non-profit sources for the conduction of the present study.

Abstract
The evolution in imaging evaluation of musculoskeletal sarcomas contributed to a significant improvement in the prognosis and survival of patients with these neoplasms. The precise characterization of these lesions, using the most appropriate imaging modalities to each clinical condition presented, is of paramount importance in the design of the therapeutic approach to be instituted, with a direct impact on clinical outcomes. The present article seeks to update the reader regarding imaging methodologies in the context of local and systemic evaluation of bone sarcomas and soft tissues.
Keywords
diagnostic imaging - multimodal imaging - neoplasms, connective tissue - neoplasms, bone tissue - radiology - sarcoma* Study developed in the Orthopedic Oncology Group, Santa Izabel Hospital, Santa Casa of Misericórdia of Bahia, Salvador, BA, Brazil and the Traumato-orthopedic Service of Clementino Fraga Filho Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Publication History
Received: 16 September 2020
Accepted: 08 July 2021
Article published online:
11 November 2021
© 2021. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
Referências
- 1
Hwang S,
Panicek DM.
The evolution of musculoskeletal tumor imaging. Radiol Clin North Am 2009; 47 (03)
435-453
MissingFormLabel
- 2
Ilaslan H,
Sundaram M.
Advances in musculoskeletal tumor imaging. Orthop Clin North Am 2006; 37 (03) 375-391
MissingFormLabel
- 3
Caracciolo JT,
Letson GD.
Radiologic approach to bone and soft tissue sarcomas. Surg Clin North Am 2016; 96
(05) 963-976
MissingFormLabel
- 4
Blay JY,
Sleijfer S,
Schöffski P.
et al.
International expert opinion on patient-tailored management of soft tissue sarcomas.
Eur J Cancer 2014; 50 (04) 679-689
MissingFormLabel
- 5
Klein MJ.
Radiographic correlation in orthopedic pathology. Adv Anat Pathol 2005; 12 (04) 155-179
MissingFormLabel
- 6
Guedes A,
Oliveira MBR,
Costa FM,
Melo AS.
Updating on Bone and Soft Tissue Sarcomas Staging. [Published online: 2020–09–30]
Rev Bras Ortop. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1710331?articleLanguage=pt
MissingFormLabel
- 7
Bestic JM,
Wessell DE,
Beaman FD.
et al.
American College of Radiology ACR. Appropriateness Criteria®. Primary Bone Tumors
(revised 2019). Reston, VA: American College of Radiology. Available from: arch.acr.org/docs/69421/Narrative/
MissingFormLabel
- 8
Pennington Z,
Ahmed AK,
Cottrill E,
Westbroek EM,
Goodwin ML,
Sciubba DM.
Systematic review on the utility of magnetic resonance imaging for operative management
and follow-up for primary sarcoma-lessons from extremity sarcomas. Ann Transl Med
2019; 7 (10) 225
MissingFormLabel
- 9
Kransdorf MJ,
Bridges MD.
Current developments and recent advances in musculoskeletal tumor imaging. Semin Musculoskelet
Radiol 2013; 17 (02) 145-155
MissingFormLabel
- 10
Miller BJ,
Avedian RS,
Rajani R.
et al
Musculoskeletal Oncology Research Initiative.
What is the use of imaging before referral to an orthopaedic oncologist? A prospective,
multicenter investigation. Clin Orthop Relat Res 2015; 473 (03) 868-874
MissingFormLabel
- 11
Nystrom LM,
Reimer NB,
Dean CW,
Bush CH,
Scarborough MT,
Gibbs Jr CP.
Evaluation of imaging utilization prior to referral of musculoskeletal tumors: a prospective
study. J Bone Joint Surg Am 2015; 97 (01) 10-15
MissingFormLabel
- 12
Costa FM,
Martins PH,
Canella C,
Lopes FPPL.
Multiparametric MR imaging of soft tissue tumors and pseudotumors. Magn Reson Imaging
Clin N Am 2018; 26 (04) 543-558
MissingFormLabel
- 13
Stacy GS,
Mahal RS,
Peabody TD.
Staging of bone tumors: a review with illustrative examples. AJR Am J Roentgenol 2006;
186 (04) 967-976
MissingFormLabel
- 14
Errani C,
Kreshak J,
Ruggieri P,
Alberghini M,
Picci P,
Vanel D.
Imaging of bone tumors for the musculoskeletal oncologic surgeon. Eur J Radiol 2013;
82 (12) 2083-2091
MissingFormLabel
- 15
Greenspan A,
Jundt G,
Remagen W.
Differential diagnosis in orthopaedic oncology. 2nd ed.. Philadelphia: Lippincott
Williams & Wilkins; 2006
MissingFormLabel
- 16
Fadul D,
Fayad LM.
Advanced modalities for the imaging of sarcoma. Surg Clin North Am 2008; 88 (03) 521-537
, vi
MissingFormLabel
- 17
Sherman CE,
O'Connor MI.
Musculoskeletal tumor imaging: an orthopedic oncologist perspective. Semin Musculoskelet
Radiol 2013; 17 (02) 221-226
MissingFormLabel
- 18
Jordan DW,
Becker M,
Brady S.
et al.
American College of Radiology ACR. Appropriateness Criteria®. Radiation Dose Assessment
Introduction (revised 2020). Reston, VA: American College of Radiology. Available
from:
https://www.acr.org/-/media/ACR/Files/Appropriateness-Criteria/RadiationDoseAssessmentIntro.pdf
MissingFormLabel
- 19
Mavrogenis AF,
Angelini A,
Vottis C.
et al.
State-of-the-art approach for bone sarcomas. Eur J Orthop Surg Traumatol 2015; 25
(01) 5-15
MissingFormLabel
- 20
Musculoskeletal Tumor Society.
Systematic literature review on the use of imaging prior to referral to a musculoskeletal
oncologist. Rosemont: Musculoskeletal Tumor Society; 2018
MissingFormLabel
- 21
Miller BJ.
Use of imaging prior to referral to a musculoskeletal oncologist. J Am Acad Orthop
Surg 2019; 27 (22) e1001-e1008
MissingFormLabel
- 22
Mothiram U,
Brennan PC,
Lewis SJ,
Moran B,
Robinson J.
Digital radiography exposure indices: A review. J Med Radiat Sci 2014; 61 (02) 112-118
MissingFormLabel
- 23
Nichols RE,
Dixon LB.
Radiographic analysis of solitary bone lesions. Radiol Clin North Am 2011; 49 (06)
1095-1114 , v
MissingFormLabel
- 24
Guedes A,
Baptista PPR,
Santili C,
Yonamine ES,
Garcia HRP,
Martinez EC.
Wide resection and fibular transposition in the treatment of GCT on radius distal
end. Acta Ortop Bras 2009; 17 (03) 171-181
MissingFormLabel
- 25
Patel DB,
Matcuk Jr GR.
Imaging of soft tissue sarcomas. Linchuang Zhongliuxue Zazhi 2018; 7 (04) 35
MissingFormLabel
- 26
Peabody TD,
Gibbs Jr CP,
Simon MA.
Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am 1998; 80
(08) 1204-1218
MissingFormLabel
- 27
Oliveira MB,
Mello FC,
Paschoal ME.
The relationship between lung cancer histology and the clinicopathological characteristics
of bone metastases. Lung Cancer 2016; 96 (01) 19-24
MissingFormLabel
- 28
van der Linden YM,
Kroon HM,
Dijkstra SP.
et al;
Dutch Bone Metastasis Study Group.
Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions:
results from a randomised trial. Radiother Oncol 2003; 69 (01) 21-31
MissingFormLabel
- 29
Colleran G,
Madewell J,
Foran P,
Shelly M,
O'Sullivan PJ.
Imaging of soft tissue and osseous sarcomas of the extremities. Semin Ultrasound CT
MR 2011; 32 (05) 442-455
MissingFormLabel
- 30
Mathur M,
Jones JR,
Weinreb JC.
Gadolinium deposition and nephrogenic systemic fibrosis: A radiologist's primer. Radiographics
2020; 40 (01) 153-162
MissingFormLabel
- 31
Shankar PR,
Davenport MS.
Risk of nephrogenic systemic fibrosis in stage 4 and 5 chronic kidney disease following
group II gadolinium-based contrast agent administration: Subanalysis by chronic kidney
disease stage. Radiology 2020; 297 (02) 447-448
MissingFormLabel
- 32
Costa FM,
Canella C,
Gasparetto E.
Advanced magnetic resonance imaging techniques in the evaluation of musculoskeletal
tumors. Radiol Clin North Am 2011; 49 (06) 1325-1358 , vii–viii
MissingFormLabel
- 33
Harry VN,
Semple SI,
Parkin DE,
Gilbert FJ.
Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol
2010; 11 (01) 92-102
MissingFormLabel
- 34
Padhani AR,
Miles KA.
Multiparametric imaging of tumor response to therapy. Radiology 2010; 256 (02) 348-364
MissingFormLabel
- 35
Hamstra DA,
Rehemtulla A,
Ross BD.
Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.
J Clin Oncol 2007; 25 (26) 4104-4109
MissingFormLabel
- 36
Koh DM,
Collins DJ.
Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am
J Roentgenol 2007; 188 (06) 1622-1635
MissingFormLabel
- 37
Gasparotti R,
Pinelli L,
Liserre R.
New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay.
Insights Imaging 2011; 2 (03) 335-347
MissingFormLabel
- 38
Miwa S,
Otsuka T.
Practical use of imaging technique for management of bone and soft tissue tumors.
J Orthop Sci 2017; 22 (03) 391-400
MissingFormLabel
- 39
Maki RG,
Moraco N,
Antonescu CR.
et al.
Toward better soft tissue sarcoma staging: building on american joint committee on
cancer staging systems versions 6 and 7. Ann Surg Oncol 2013; 20 (11) 3377-3383
MissingFormLabel
- 40
Callegaro D,
Miceli R,
Bonvalot S.
et al.
Development and external validation of two nomograms to predict overall survival and
occurrence of distant metastases in adults after surgical resection of localised soft-tissue
sarcomas of the extremities: a retrospective analysis. Lancet Oncol 2016; 17 (05)
671-680
MissingFormLabel
- 41
Ferrari A,
Dirksen U,
Bielack S.
Sarcomas of soft tissue and bone. Prog Tumor Res 2016; 43: 128-141
MissingFormLabel
- 42
Kneisl JS,
Rosenberg AE,
Anderson PM.
et al.
Part VIII Bone. In:
Amin MB,
Edge S,
Greene F.
et al, editors. AJCC Cancer Staging Manual. 8th ed.. Switzerland: Springer; 2017:
469-486
MissingFormLabel
- 43
Steffner RJ,
Jang ES.
Staging of bone and soft-tissue sarcomas. J Am Acad Orthop Surg 2018; 26 (13) e269-e278
MissingFormLabel
- 44
Cates JM.
Comparison of the AJCC, MSTS, and modified Spanier systems for clinical and pathologic
staging of osteosarcoma. Am J Surg Pathol 2017; 41 (03) 405-413
MissingFormLabel
- 45
Chang CY,
Gill CM,
Joseph Simeone F.
et al.
Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG
PET/CT for the detection of skeletal metastases. Acta Radiol 2016; 57 (01) 58-65
MissingFormLabel
- 46
Ell PJ,
Gambhir S.
Nuclear Medicine in Clinical Diagnosis and Treatment. 3rd edition.. Philadelphia:
Churchill Livingstone; 2004
MissingFormLabel
- 47
McKillop JH,
Etcubanas E,
Goris ML.
The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a
review of 55 patients. Cancer 1981; 48 (05) 1133-1138
MissingFormLabel
- 48
Shen G,
Deng H,
Hu S,
Jia Z.
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of
bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol
2014; 43 (11) 1503-1513
MissingFormLabel
- 49
Pasoglou V,
Michoux N,
Tombal B,
Jamar F,
Lecouvet FE.
WbMRI to detect bone metastases: Critical review on diagnostic accuracy and comparison
to other imaging modalities. Clin Transl Imaging 2015; 3: 141-157
MissingFormLabel
- 50
Morone M,
Bali MA,
Tunariu N.
et al.
Whole-Body MRI: Current applications in oncology. AJR Am J Roentgenol 2017; 209 (06)
W336-W349
MissingFormLabel
- 51
Hochhegger B.
Whole-body magnetic resonance imaging: an effective and underutilized technique. Radiol
Bras 2015; 48 (03) IX-X
MissingFormLabel
- 52
Wilhelm T,
Stieltjes B,
Schlemmer HP.
Whole-body-MR-diffusion weighted imaging in oncology. Röfo Fortschr Geb Röntgenstr
Nuklearmed 2013; 184 (10) 950-958
MissingFormLabel
- 53
Jacobs MA,
Macura KJ,
Zaheer A.
et al.
Multiparametric whole-body MRI with diffusion-weighted imaging and ADC mapping for
the identification of visceral and osseous metastases from solid tumors. Acad Radiol
2018; 25 (11) 1405-1414
MissingFormLabel
- 54
Barchetti F,
Stagnitti A,
Megna V.
et al.
Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases
after primary treatment. Eur Rev Med Pharmacol Sci 2016; 20 (18) 3770-3776
MissingFormLabel
- 55
Behzadi AH,
Raza SI,
Carrino JA.
et al.
Applications of PET/CT and PET/MR Imaging in primary bone malignancies. PET Clin 2018;
13 (04) 623-634
MissingFormLabel
- 56
Eiber M,
Takei T,
Souvatzoglou M.
et al.
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation
of malignant bone lesions. J Nucl Med 2014; 55 (02) 191-197
MissingFormLabel
- 57
Etchebehere EC,
Hobbs BP,
Milton DR.
et al.
Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue
musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med
Mol Imaging 2016; 43 (05) 860-870
MissingFormLabel
- 58
London K,
Stege C,
Cross S.
et al.
18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone
tumors. Pediatr Radiol 2012; 42 (04) 418-430
MissingFormLabel
- 59
Ehman EC,
Johnson GB,
Villanueva-Meyer JE.
et al.
PET/MRI: Where might it replace PET/CT?. J Magn Reson Imaging 2017; 46 (05) 1247-1262
MissingFormLabel
- 60
Martin O,
Schaarschmidt BM,
Kirchner J.
et al.
PET/MRI versus PET/CT for whole-body staging: results from a single-center observational
study on 1,003 sequential examinations. J Nucl Med 2020; 61 (08) 1131-1136
MissingFormLabel